From my colleague Adam Feuerstein: French drug maker Sanofi is acquiring the small biotech Vigil Neuroscience for $470 ...

The FDA has updated COVID-19 vaccine regulations. Only people aged 65 and up, along with certain groups, will be eligible to ...

The U.S. Food and Drug Administration's advisory panel is set to vote on Thursday to recommend whether COVID-19 vaccines for ...

The changes by the FDA mean restricting access to who can get seasonal COVID shots—limiting approval to seniors over 65, ...

The Conversation asked Nicole Hassoun, a professor at Binghamton University and executive director of Global Health Impact, to explain the pandemic accord, its prospects for advancing global health, ...

Government vaccine advisers are meeting to decide if the recipe for COVID-19 vaccines needs updating for this fall and winter ...

Private equity ownership of psychiatric hospitals grew rapidly from 2013 to 2021, but the quality of care did not diminish ...

Letter: What I do not understand is why, almost immediately after announcing these tariffs, President Trump agrees to suspend ...

The Food and Drug Administration says it has decided to continue approving COVID-19 vaccine updates for seniors and others at ...

The Food and Drug Administration will no longer approve COVID-19 vaccines for healthy people under 65 without rigorous trials ...

FDA Warns of Heart Risk With Pfizer, Moderna COVID Vaccines THURSDAY, May 22, 2025 (HealthDay News) — The U.S. Food and Drug ...

The FDA will now require clinical trials to approve boosters for healthy Americans under 65, making it unlikely the shots ...